Table 3.
Tau-Immunoreactive Pathology in CBD, IHC
| Patient | Frontal lobe | Temporal lobe | Parietal lobe | Occipital lobe | Basal ganglia | Cerebellum | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grey matter | White matter | Grey matter | White matter | Grey matter | White matter | Grey matter | White matter | Striatum | Globus pallidus | Folia | White matter | |
| 1 | 2 | 3 | NA | NA | 2 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
| 2 | 1 | 3 | 1 | 1 | NA | NA | NA | NA | 3 | 3 | 0 | 2 |
| 3 | 3 | 3 | 1 | 0 | 2 | 2 | NA | NA | 2 | 3 | 0 | 2 |
| 4 | 3 | 3 | 2 | 2 | 2 | 2 | NA | NA | 3 | 3 | 0 | 2 |
| 5 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 0 | NA |
| 6 | 3 | 3 | 2 | 2 | 2 | 2 | 0 | 0 | 3 | 3 | 0 | NA |
| 7 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 1 | 3 | NA | 0 | NA |
| 8 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | NA | 3 | 0 | 1 |
| 9 | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 1 | 3 | 3 | 0 | 2 |
| 10 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 3 | 3 | 0 | 1 |
| 11 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 3 | 0 | 2 |
| 12 | 3 | 3 | 2 | 2 | 3 | 3 | 0 | 0 | 3 | 3 | 0 | 2 |
Frontal lobe, mid-frontal gyrus; temporal lobe, superior temporal gyrus; parietal lobe, inferior parietal lobule; occipital lobe, calcarine cortex.
0, absent; 1, mild density; 2, moderate density; 3, high density; NA, not available.